First Quadrant’s PDL BioPharma PDLI Stock Holding History
Bought
Maintained
Sold
Other funds holding PDLI
First Quadrant's PDLI Position: Q3 2018 in Review
First Quadrant sold out of PDL BioPharma (PDLI) in Q3 2018, closing a stake of 9,813 shares — an estimated $23K sold.
First Quadrant first reported a position in PDLI in Q2 2013 and held it in 13 quarters. The position peaked at $2.14M in Q4 2013. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.
- First Quadrant reported no remaining PDL BioPharma position as of Q3 2018 after selling out during the quarter.
- First Quadrant sold 9,813 PDL BioPharma shares in Q3 2018, an estimated $23K.
- First Quadrant first reported a position in PDL BioPharma in Q2 2013 and held it in 13 quarters.
- First Quadrant's PDL BioPharma position peaked at $2.14M in Q4 2013.
- 152 funds tracked by Wall St. Rank held PDL BioPharma as of Q3 2018.
Based on First Quadrant's 13F filing for Q3 2018, filed 23 Oct 2018.